| 1 | 08:40-09:00 | 专题报告 |
PAELCA手术技术标准的建立 |
|
||||
| 2 | 09:00-09:20 | 专题报告 |
经支气管多种能量模式治疗早期周围型肺癌:现状与展望 |
|
||||
| 3 | 09:20-09:40 | 专题报告 |
微创消融治疗早期肺癌的现状与思考 |
|
||||
| 1 | 09:45-10:05 | 专题报告 |
形状感知机器人支气管镜下消融治疗 |
|
||||
| 2 | 10:05-10:25 | 专题报告 |
经气道冷冻消融治疗周围型肺癌的初步探索 |
|
||||
| 3 | 10:25-10:45 | 专题报告 |
肺癌消融治疗常见并发症及安全性分析 |
|
||||
| 1 | 10:50-11:10 | 专题报告 |
重症肺癌呼吸内镜介入治疗进展 |
|
||||
| 2 | 11:10-11:30 | 专题报告 |
肺癌消融治疗的前沿探索 |
|
||||
| 1 | 11:35-11:40 | 论文发言 |
Subcutaneous Envafolimab Combined with Oral Metronomic Vinorelbine as First-Line Treatment for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Single-Arm Phase II Study |
|
||||
| 2 | 11:40-11:45 | 论文发言 |
Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification |
|
||||
| 3 | 11:45-11:50 | 论文发言 |
A Redox-Balancing Silver–Platinum–Indocyanine Green Nanoplatform for Near-Infrared-Activated Precision Therapy of Lung Cancer |
|
||||
| 4 | 11:50-11:55 | 论文发言 |
晚期肺腺癌靶向治疗全程管理模式的设计与探索 |
|
||||